Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

Toxicity Testing in Animals

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...

In vitro Mutagenesis

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

In-vitro Mutagenesis

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Identification of an alginate-based formulation of paraquat to reduce the exposure of the herbicide following oral ingestion.

Toxicology·2007

Same author

Adult vs. adolescent rats differ in biobehavioral responses to chronic nicotine administration.

Pharmacology, biochemistry, and behavior·2002

Same author

Contemporary analysis of outcomes following lower extremity bypass in patients with end-stage renal disease.

Annals of vascular surgery·2001

Same author

Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel.

International journal of cancer·2001

Same author

The mutagenic potential of acetonitrile in the bone marrow and peripheral blood of the mouse.

Mutagenesis·2001

Same author

Symptoms of chronic arterial insufficiency correlate with absolute ankle pressure better than with ankle: brachial index.

Minerva cardioangiologica·2000

Same journal

PM<sub>2.5</sub> exposure impairs mitochondrial function and myocardial contractility in cardiac organoids via the Sirt3/Mdh2 pathway.

Toxicology in vitro : an international journal published in association with BIBRA·2026

Same journal

Evaluation of an in-vitro test protocol using a three-dimensional human buccal oral mucosal model to assess the oral medical devices.

Toxicology in vitro : an international journal published in association with BIBRA·2026

Same journal

Descriptive oxidative and lipid-related fluorescence observations associated with Esketamine treatment in a high-concentration NMDA-exposed HT-22/C8-D1A co-culture model.

Toxicology in vitro : an international journal published in association with BIBRA·2026

Same journal

Integration of label-free electrochemical sensing, differential privacy deep learning, and blockchain for secure cytotoxicity monitoring.

Toxicology in vitro : an international journal published in association with BIBRA·2026

Same journal

Pulmonary permeability assessment using two human lung epithelial cell models in air-liquid interface cultures.

Toxicology in vitro : an international journal published in association with BIBRA·2026

Same journal

In vivo toxicity of some cyanide-containing compounds in zebrafish (Danio rerio) embryos.

Toxicology in vitro : an international journal published in association with BIBRA·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 10, 2026

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

Genotoxicity testing strategies.

¹Zeneca Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, UK.

Toxicology in Vitro : an International Journal Published in Association with BIBRA

|August 10, 2010

Summary

This summary is machine-generated.

Genotoxicity testing assesses chemical risks for cancer or mutations. Harmonizing testing strategies based on established precedents, rather than potential risks, can simplify evaluations.

More Related Videos

The Lambda Select cII Mutation Detection System

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

Related Experiment Videos

Last Updated: Jun 10, 2026

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

The Lambda Select cII Mutation Detection System

The Lambda Select cII Mutation Detection System

Published on: April 26, 2018

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

Area of Science:

Toxicology
Genetics
Chemical Safety Assessment

Background:

Genotoxicity tests evaluate a chemical's potential to cause cancer or heritable mutations.
Current genotoxicity testing follows a stepwise in vitro and in vivo approach.
Debate exists regarding the optimal number and timing of in vitro and in vivo assays.

Purpose of the Study:

To propose a more harmonized and simplified approach to genotoxicity testing strategies.
To advocate for basing testing protocols on established precedents for detecting carcinogens or mutagens.

Main Methods:

Review of current genotoxicity testing principles and practices.
Analysis of the rationale behind stepwise in vitro and in vivo testing.
Discussion on the potential for harmonizing testing strategies.

Main Results:

Genotoxicity testing is crucial for assessing chemical-induced somatic or germ-cell effects.
A stepwise approach involving in vitro and in vivo assays is standard practice.
Current strategies could be improved by focusing on established precedents.

Conclusions:

Harmonizing genotoxicity testing strategies requires a shift towards evidence-based protocols.
Utilizing knowledge of precedents for detecting carcinogens and mutagens can simplify and optimize testing.
Standardized strategies based on historical success will enhance chemical safety assessments.